2-(Methoxymethyl)-2-methylbutanenitrile

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-(Methoxymethyl)-2-methylbutanenitrile
• 英文别名: 2-(methoxymethyl)-2-methylbutanenitrile
• 化学式: C₇H₁₃NO
• 分子量: 127.18
• InChiKey: OVXPUVXWPJNARB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  33
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• SUBSTITUTED 4-PYRIDONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY
  申请人：OOST Thorsten

  公开号：US20140057916A1

  公开（公告）日：2014-02-27

  This invention relates to substituted 4-pyridones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other auto-immune and allergic disorders, allograft rejection, and oncological diseases.

  这项发明涉及式1的取代4-吡啶酮及其作为中性粒细胞弹性蛋白酶活性抑制剂的用途，包含这些化合物的药物组合物，以及将其用作治疗和/或预防肺部、胃肠道和泌尿系统疾病、皮肤和眼睛的炎症性疾病以及其他自身免疫和过敏性疾病、移植物排斥反应和肿瘤性疾病的药剂的方法。
• [EN] PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉS ACIDE 1H-PYRAZOLE-5-CARBOXYLIQUE N-SUBSTITUÉS ET DE LEURS DÉRIVÉS
  申请人：BASF SE

  公开号：WO2014184343A1

  公开（公告）日：2014-11-20

  The present invention relates to a process for preparing N-substituted 1 H-pyrazole-5-carboxylic acid compounds of the formula l-A and derivatives thereof, in particular the corresponding carbonylchloride compounds (acid chlorides). It also relates to the use of these acid chlorides for preparing anthranilamide derivatives that are useful pesticides. in which the variables are as defined in the claims and the specification comprising the steps of i) reacting a compound of the formula (II) with a base selected from combinations of a magnesium-organic compound having a carbon bound magnesium and a secondary amine and magnesium amides of secondary amines in the presence of a lithium halide, where the base is used in an amount sufficient to achieve at least 80 % deprotonation of the compound of formula (II); and subjecting the product obtained in step (i) to a carboxylation by reacting it with carbon dioxide or a carbon dioxide equivalent, to obtain a magnesium salt of the compound of formula (l-A) and optionally aqueous workup to obtain the compound of the formula (l-A) as a free acid.

  本发明涉及一种制备N-取代1H-吡唑-5-羧酸化合物及其衍生物的方法，特别是相应的羰基氯化合物（酸氯化物）。还涉及使用这些酸氯化物来制备对昆虫有用的蒽醯胺衍生物杀虫剂。其中变量如索赔中所定义和规范中包括以下步骤：i）将式（II）的化合物与选择自具有碳键镁的有机镁化合物和次级胺以及次级胺的镁酰胺的组合的碱在锂卤化物存在下反应，其中所述碱的用量足以实现式（II）的化合物至少80%的脱质子化；并将在步骤（i）中获得的产物经羧化反应，与二氧化碳或二氧化碳等效物反应，以获得化合物的镁盐（l-A）和可选的水工艺处理以获得化合物的自由酸形式（l-A）。
• 5-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO- AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE
  申请人：Wu Wen-Lian

  公开号：US20140128382A1

  公开（公告）日：2014-05-08

  The present invention discloses certain iminothiazine compounds and mono- and dioxides thereof, including compounds Formula (I): and tautomers and stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomers and said stereoisomers, wherein each of variables shown in the formula are as defined herein. The compounds of the invention may be useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and uses, including Alzheimer's disease, are also disclosed.

  本发明揭示了某些亚胺噻唑化合物及其单体和二氧化物，包括化合物公式（I）：及其互变异构体和立体异构体，以及所述化合物、所述互变异构体和所述立体异构体的药学上可接受的盐，其中公式中所示的每个变量如本文所定义。本发明的化合物可用作BACE抑制剂和/或用于治疗和预防与之相关的各种病理学。本发明还揭示了包括一种或多种此类化合物（单独和与一种或多种其他活性剂组合）的制药组合物，以及其制备和用途的方法，包括阿尔茨海默病。
• PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF
  申请人：BASF SE

  公开号：EP2997020A1

  公开（公告）日：2016-03-23
• US9102624B2
  申请人：——

  公开号：US9102624B2

  公开（公告）日：2015-08-11